Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Dyslipidemias”

137 trials

Showing 20 of 137 results

Large-scale testing (Phase 3)Study completedNCT04643093
What this trial is testing

Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemias
Orient Pharma Co., Ltd. 390
Not applicableActive Not RecruitingNCT04579367
What this trial is testing

Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 5,000
Large-scale testing (Phase 3)WithdrawnNCT05809687
What this trial is testing

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Who this might be right for
Dyslipidemias
Dongkwang Pharm. Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT00269217
What this trial is testing

Lipid Efficacy Study (0524B-022)(COMPLETED)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 1,400
Large-scale testing (Phase 3)Study completedNCT00376584
What this trial is testing

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Who this might be right for
HypercholesteremiaHyperlipidemia
Merck Sharp & Dohme LLC 825
Early research (Phase 1)Study completedNCT00565292
What this trial is testing

MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 50
Not applicableStudy completedNCT04063137
What this trial is testing

Black Rice Anthocyanin in Mixed Meals: Influence on Postprandial Glycaemic and Lipid Responses Among Healthy Individuals

Who this might be right for
Postprandial HyperglycemiaLipidemia
National University of Singapore 24
Testing effectiveness (Phase 2)Study completedNCT00941603
What this trial is testing

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 619
Large-scale testing (Phase 3)Study completedNCT00092573
What this trial is testing

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
Organon and Co 576
Post-approval studies (Phase 4)Study completedNCT01551173
What this trial is testing

Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Lipid Metabolism Disorders
Novartis Pharmaceuticals 436
Large-scale testing (Phase 3)Study completedNCT00352183
What this trial is testing

Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

Who this might be right for
Cardiovascular Diseases
Solvay Pharmaceuticals 450
Large-scale testing (Phase 3)WithdrawnNCT02670434
What this trial is testing

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

Who this might be right for
HyperlipidemiaDyslipidemia
Kowa Research Institute, Inc.
Testing effectiveness (Phase 2)Study completedNCT04998201
What this trial is testing

Study of ARO-APOC3 in Adults With Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
Arrowhead Pharmaceuticals 353
Large-scale testing (Phase 3)Study completedNCT00349375
What this trial is testing

Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

Who this might be right for
Hyperlipidemia
Solvay Pharmaceuticals 1,040
Large-scale testing (Phase 3)Study completedNCT00465088
What this trial is testing

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Abbott 199
Not applicableUnknownNCT03648788
What this trial is testing

A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

Who this might be right for
Mixed Dyslipidemia
IlDong Pharmaceutical Co Ltd 600
Not applicableUnknownNCT06204380
What this trial is testing

An Observational Study on the Identification of Prescription Patterns of STAFEN Cap

Who this might be right for
Mixed Dyslipidemia
Hanlim Pharm. Co., Ltd. 4,000
Large-scale testing (Phase 3)Study completedNCT04885218
What this trial is testing

Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia

Who this might be right for
Non-familial HypercholesterolemiaMixed Hyperlipidemia
Jiangsu HengRui Medicine Co., Ltd. 692
Large-scale testing (Phase 3)Study completedNCT01968967
What this trial is testing

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Who this might be right for
Hyperlipidemia
Pfizer 2,139
Large-scale testing (Phase 3)Study completedNCT01953328
What this trial is testing

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Who this might be right for
Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
Amgen 409
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation